Abstract
This paper analyzes the results of combined treatment with preoperative thermochemoradiotherapy in 28 patients with locally advanced laryngeal cancer (T3-4N0-3M0). Radiation therapy (RT) 32 Gy was carried out 5 times a week with splitting the daily dose of radiation on the 2 factions (interval 4 hours) on a «1 Gy+1 Gy,» in the days of the local hyperthermia (LGT) — on a «1 Gy+3 Gy». LGT in an amount of 3-4 sessions was performed two times a week before the 2nd fraction of RT. The course of polychemotherapy was administered concurrently with RT and LGT. In 2-3 weeks after completion of the course thermochemoradiotherapy patients were operated. Organ-saving operations were performed 10 (56%) of 18 patients with primary tumors categories T3 and 2 (20%) of 10 with T4. Postoperative wounds healed by first intention in 21 (75%) patients. The cumulative 5-year overall survival in the whole group (T3-4N0-3) was 89%, for patients without regional metastases (T3-4N0) — 100%. Relapse-free survival time for those patients with a primary tumor T3 equaled 94%, T4 — 90%. Relapse metastases occurred in 20% of patients. Thus, preoperative thermochemoradiotherapy is a highly effective method of treatment for locally advanced cancer of the larynx and does not lead to the development of severe postoperative complications.References
Алферов В.С. Органосохраняющее лечение рака гортани // Мат. V Росс. онкол. конф. — 2000. — С. 80-81.
Андреев В.Г., Мардынский Ю.С. Лучевое и комбинированное лечение рака гортани. М. — 1998. — С. 115.
Курпешев О.К., Цыб А.Ф., Мардынский Ю.С. и др. Локальная гипертермия в лучевой терапии злокачественных опухолей (экспериментально-клиническое исследование). Обнинск. — 2007. — С. 219.
Чижевская С.Ю., Чойнзонов Е.Л. Современные возможности и перспективы комбинированного лечения рака гортани и гортаноглотки // Сиб. онкол. журнал. 2007. — № 4 (24). — С. 127-132.
Cosetti M., Yu G.P., Schantz S.P. Five-year survival rates and time trends of laryngeal cancer in the US population // Arch Otolaryngol. Head Neck Surg. — 2008. — Vol. 134. — No. 4. — P. 370-379.
Eisenhauer E.A., Therasse P., Bogaerts J. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (v. 1.1) // Eur. J. Cancer. — 2009. — Vol. 45. — P. 228-247.
Foote R.L., Foote R.T., Brown P.D. et al. Organ preservation for advanced laryngeal carcinoma // Head Neck. — 2006. — Vol. 28. — P. 689-696.
Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations // J. Amer. Stat. Ass. — 1958. — Vol. 53. — P. 457-81.
Kaur P., Hurwitz M.D., Krishnan S., Asea A. Combined Hyperthermia and Radiotherapy for the Treatment of Cancer // Cancers. — 2011.- P. 3799-3823.
Majem M., Mesia R., Manós M. et al. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d’Oncologia in stage III larynx carcinoma // Laryngoscope. — 2006. — Vol. 116. — P. 1651-1656.
Spriano G., Antognoni P., Sanguineti G. et al. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy // Am. J. Otolaryngol. — 2000. — Vol. 21. — 1. — P. 14-21.
Terrell J.E., Fisher S.G., Wolf G.T. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group // Arch Otolaryngol. Head Neck Surg. — 1998. — Vol. 124. — P. 964-971.
Tufano R.P, Stafford E.M. Organ preservation surgery for laryngeal cancer // Otolaryngol. Clin. North. Amer. — 2008. — Vol. 41. — P. 741-755.
Van der Zee J., Vujaskovic Z., Kondo M., Sugahara T. Part I. Clinical Hyperthermia. The Kadota Fund International Forum 2004 — Clinical group consensus // Int. J. Hypert. — 2008. — Vol. 24. — P. 111-122.
Yeager L.B., Grillone G.A. Organ preservation surgery for intermediate size (T2 and T3) laryngeal cancer // Otolaryngol. Clin. Noth Amer. — 2005. — Vol. 38. — P 11-20.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...